ORIGINAL RESEARCH article
Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1651306
Prenatal Diagnosis and Molecular Characterization of PKHD1 Variants in two Chinese Fetuses with Caroli Disease/Syndrome
Provisionally accepted- Maternal and Child Health Hospital of Hubei Province, Wuhan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Caroli disease (CD) and Caroli syndrome (CS) are rare inherited disorders characterized by dilatation of intrahepatic bile ducts, caused by PKHD1 pathogenic variants. Prenatal diagnosis of CD or CS is extremely rare, with only two cases having genetic analysis worldwide. In this study, we describe the prenatal imaging and genetic findings in two Chinese fetuses with CD/CS. Methods: Prenatal ultrasound and magnetic resonance imaging (MRI) findings were collected for both fetuses. Whole exome sequencing was performed in family 1 and fetus 2, using fetal umbilical cord and parental peripheral blood. The candidate variants were validated using Sanger sequencing. The effect of the splice site variant was evaluated by in vitro minigene assays with the pcMINI-C and pcMINI vectors. Results: Both fetuses presented with multiple dilated intrahepatic bile ducts and features consistent with autosomal recessive polycystic kidney disease (ARPKD) on ultrasound and MRI at 33 weeks (Fetus 1) and 39 weeks (Fetus 2) gestation; Fetus 2 also exhibited oligohydramnios. Trio WES analysis revealed two compound heterozygous variants of PKHD1, a missense variant c.7912T>A (p.Tyr2638Asn) and an intronic splice-site variant c.3364+3A>T, in Fetus 1, with the father carrying c.7912T>A and the mother c.3364+3A>T. WES analysis in Fetus 2 identified two PKHD1 candidate variants, c.9901G>T (p.Glu3301Ter) and c.2507T>C (p.Val836Ala). These variants were confirmed by Sanger sequencing, and in silico prediction and conservation analysis suggested their potential pathogenicity. The c.3364+3A>T variant has been previously reported postnatally but functionally uncharacterized. In vitro minigene assays demonstrated that it caused exon 29 skipping, leading to a frameshift and a premature stop codon (c.3229_3364del p.Gly1077Alafs*12). This is a provisional file, not the final typeset article Conclusion: We reported the first prenatally diagnosed CD/CS cases with genetic analysis in the Chinese population, and experimentally validated the pathogenicity of the recurrent splice site variant c.3364+3A>T by a minigene assay. Our findings broaden the PKHD1 variation spectrum in these rare cases and recommend including prenatal cases to refine the reported genotype-phenotype correlations. We also emphasize the need of WES in probands with CD or CS for early molecular diagnosis in subsequent pregnancies.
Keywords: Caroli Disease, Caroli syndrome, Autosomal Recessive Polycystic Kidney Disease, PKHD1 gene, Fetus, Prenatal Diagnosis, whole exome sequencing, minigene assay
Received: 21 Jun 2025; Accepted: 15 Sep 2025.
Copyright: © 2025 Huang, Zhao, Wang, Pan, Liu, Chen and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Peiwen Chen, 191287662@qq.com
Xinlin Chen, 928339431@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.